Drug Type Mesenchymal stem cell therapy |
Synonyms- |
Target- |
Mechanism Stem cell replacements |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lupus Vulgaris | Phase 2 | ID | 01 Aug 2022 | |
Rheumatoid Arthritis | Phase 2 | ID | 01 Aug 2022 | |
Systemic Lupus Erythematosus | Phase 2 | ID | 01 Aug 2022 |